US biotech company Moderna has been given emergency use authorization from the Indian government for its Covid-19 Vaccine Moderna (mRNA-1273) in adults aged 18 years and older.

In this connection, the company has been given a registration certificate from the government along with permission to import the vaccine to India for restricted use in an emergency situation.

Stéphane Bancel – CEO of Moderna said: “I want to thank the government of India for this authorization, which marks an important step forward in the global fight against the pandemic.

“We are committed to making our COVID-19 vaccine available around the world.”

Apart from Moderna’s vaccine, India had approved Covishield, Covaxin, and Sputnik V.

Moderna also has emergency (or other conditional, interim or provisional) authorization for use of the Covid-19 Vaccine Moderna from health agencies in 50 plus countries and also an emergency use listing (EUL) from the World Health Organization (WHO).

The Covid-19 Vaccine Moderna contains messenger RNA (mRNA), which is a genetic material. The vaccine has a small piece of the mRNA of the Covid-19 causing SARS-CoV-2 virus which informs cells in the body to make the virus’ distinctive “spike” protein.

  Coronavirus, COVID-19, COVID-19 Vaccine Moderna, India, Moderna, mRNA-1273, SARS-CoV-2 virus, Stéphane Bancel